At the news
? BULLISHIMPACT 5/10 8-K filed Jun 29, 2026 at 11:14 ET
Emergent BioSolutions received a $52.7 million contract modification from the U.S. government (ASPR) for ACAM2000 vaccine supply under an existing 10-year contract. Deliveries begin June 2026, with diluent lots by December 2026. This is a material but routine government award, providing near-term revenue visibility.
- Contract modification valued at $52.7 million from ASPR for ACAM2000 vaccine
- Deliveries of doses and ancillaries to begin June 2026; diluent replacement lots by December 2026
- Modification exercises Option Year 7 under existing 10-year contract (75A50119C00071)
- Recent international approvals: Saudi FDA and Singapore HSA expanded ACAM2000 indications for mpox
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access